IRVINE CA--(Marketwire - Sep 5, 2012) - Vivakor Inc. (PINKSHEETS: VIVK) announced today that the Company has finalized the investment plans for Well-Med Global LLC. which includes royalties on all sales. The investment plans call for an investment of up to $10 million over the next two years to assist Well-Med Global in its growth. Well-Med Global currently distributes proprietary skin care products that contain (TGF) Tissue Growth Factors that aid in the regeneration of cells. Additionally the Company has added Tom Lee, founder and CEO of Well-Med Global LLC, to its Board of Directors focusing on the Asian Market.
CEO and Chairman Matt Nicosia added, "Vivakor is pleased with this acquisition and partnership with Well-Med Global. Well-Med Global is in revenue generation and fits our acquisition strategy as the management team and product have a synergistic relationship not only in with product categories but in management philosophy. The Well-Med Global products are the top of the industry and we look forward to assisting Well-Med Global's growth as we believe it has a $500 million direct international market opportunity over the next five years. We are also very pleased to add Tom Lee to the Board of Directors of Vivakor as his knowledge and experience will add to Vivakor's ability to access both opportunities and investors in the Asian market."
CEO of Well-Med Global LLC, Tom Lee, added," We are pleased with the opportunity to join Vivakor's family of assets and believe that the investment support will assist the explosive growth we are already experiencing here at Well-Med Global. Our products are revolutionary and have redefined the standard of care in topical treatment products. I also look forward to adding value to Vivakor's board of Directors as it continues to increase its asset base with other revenue producing assets worldwide."
About Vivakor, Inc.
Vivakor, Inc. is an asset acquisition company that develops and acquires assets that generate revenue currently or in the near term. The Company acquires technologies and assets in the fields of precious minerals, biotechnology, and alternative energy. We have several mineral assets that have great value and both create a cash flow and a long term revenue stream for the Company. We have effectively acquired positions in other Green Energy companies. We have several operating assets that produce revenues and cash flow to the company. Our business model is to acquire cash-flowing or near term cash-flowing mineral and or technology assets that an identified need or a substantial market opportunity with a significant market. For more information please visit www.vivakor.com.
About Well-Med Global LLC.
Well-Med Global, LLC was established to identify and offer scientifically proven products and services that are unique for the Health and Beauty Marketplaces. Products are based on breakthrough science and technology and have the potential to be the leaders in the global marketplace. Each product is carefully scrutinized for the benefits and enhanced properties to make it the best available product in efficacy and value. Currently, the main product focus is topical skin care collections using medical grade products and services that are based on stem cell and Growth Factor (GF) biotechnology. These products are manufactured in an FDA approved facility. WELL-MED Global products are manufactured exclusively in the United States meeting established product specifications. For more information please visit www.wellmedglobal.com.
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.